Top

Carrot Medical Finishes EBITDA Positive and Posts Record 2015 Results!

Carrot Medical - the leader in advanced audio, visual and IT solutions for Interventional Labs - is pleased to report preliminary 2015 numbers that equate to a record year. Key financial metrics for the fourth quarter - and fiscal year 2015 - were all favorable once again. Comparing Q4, 2015 to Q4, 2014, revenue increased by 25% and gross profit improved by 27%. On the year-over-year basis, revenue also increased by 51% and gross profit grew by 25% in 2015 compared to 2014. Additionally, OPEX decreased by 9% and EBITDA improved by 105% in 2015 compared to the same period in 2014. “The big story for Carrot Medical in 2015 was running the business profitably for the first time in the history of the...

Carrot Medical - the leader in...

Read More

Carrot Medical at the 21st Annual Atrial Fibrillation (AF) Symposium

Carrot Medical will be supporting Boston Scientific (Booth #300) with the industry leading C-View Pro (Large Display Video Integration) System at the AF Symposium - January 14th - 16th, in Orlando, FL.  Stop by and see the latest innovations from Boston Scientific synchronized on a C-View Pro Ultra HD Display....

Carrot Medical will be support...

Read More

2015 Will Be A Banner Year For Carrot Medical

Carrot Medical recently closed key deals for (6) more Flagship C-View / C-View Pro Systems in the 4th Quarter. Several more C-Com and C-Suite Systems were either sold or installed in the quarter as well with a month to go. Revenue, OPEX and EBITDA all continue to trend in the right direction and will easily surpass the prior year. “As we’ve anticipated - 2015 will be an extremely positive year for Carrot Medical in several ways,” said Jeremy Wiggins, Carrot Medical CEO. “Our revised up revenue target, profitability and 2016 backlog all appear extremely favorable given our current line of sight with a third of the quarter left. The 2015 accomplishments are a tribute to the hard work of the...

Carrot Medical recently closed...

Read More

A Robust Q3 for Carrot Medical ~ Positioned for a Record Year

Carrot Medical is pleased to report a very robust finish to Q3, 2015 and YTD numbers. Key financial metrics (Revenue, OPEX, and EBITDA) were all favorable once again. Comparing Q3, 2015 to Q3, 2014, revenue increased by 62% and gross profit improved by 6%. On the year-to-date basis, revenue also increased by 62% and gross profit grew by 24% in 2015 compared to 2014. For the first nine months of 2015, OPEX decreased by 18% and EBITDA improved by 105% compared to the same period in 2014. “We just closed orders for (3) more C-View (Large Display) Systems - our Flagship Platform - which kicks off Q4 nicely,” said Jeremy Wiggins, Carrot Medical CEO. “Carrot certainly continues its momentum and is literally on...

Carrot Medical is pleased to r...

Read More

Carrot Medical and Attention to Quality

Carrot Medical - a leader in interventional lab solutions - has been an ISO 13485:2003 compliant company for several years. The ISO standard specifies the requirements for comprehensive Quality Management Systems in the design and manufacture of medical devices. The certification represents Carrot Medical’s commitment to providing the highest quality products to its customers and emphasizes Carrot’s culture of continuous improvement. Carrot Medical’s annual audit - performed by British Standards Institution (BSI) - occurred on September 10th & 11th, 2015. The Company is very proud to report that the audit uncovered no findings and that Carrot Medical is being recommended for re-certification once again. “To have zero findings on our recent audit is really quite an accomplishment by the Carrot Medical Team....

Carrot Medical - a leader in i...

Read More

Carrot Medical Starts Q3 Strong

July 2015 revenue increased by 10% and operating expenses decreased by 3% compared to the same period in 2014. On the year-to-date basis, revenue in 2015 grew by 42%, gross profit improved by 9%, operating expenses decreased by 25% and EBITDA increased by 96% compared to the first seven months of 2014. “Carrot is off to a very strong start for the third quarter,” said Nicole Ressler, Carrot Medical CFO. “We continue to build and foster strategic alliances with our partners and customers. They see our commitment to high quality products and services and this is resulting in a bigger footprint in the interventional space for Carrot Medical.”...

July 2015 revenue increased by...

Read More

Carrot Medical Closes Significant C-Suite Order at UCLA

Carrot Medical will augment the existing C-View Pro Large Display Systems in the EP Lab at UCLA with the C-Suite 2.0 Platform. “Carrot Medical has invested quite a bit over the past four years to develop the industry leading Recording, Streaming and Archiving technology known as C-Suite,” said Jeremy Wiggins, Carrot Medical CEO. “The days of interventional labs not recording their cases is over. State of the Art Recording & Streaming for training, education, collaboration and documentation for quality assurance purposes is not the future - it’s here today from Carrot. We are extremely proud that UCLA will also be leveraging the Carrot C-Suite Platform.”...

Carrot Medical will augment th...

Read More

Carrot Medical Closes Multiple C-View Order at St. Vincent’s

Carrot Medical closes another significant multiple C-View System order at St Vincent’s Medical Center in Jacksonville, FL. The order was for (3) industry leading C-View Systems to be installed in St. Vincent’s Cath and EP Labs. “Carrot Medical is proud to add St. Vincent’s to the long list of distinguished C-View customers,” said Jeremy Wiggins, Carrot Medical CEO....

Carrot Medical closes another ...

Read More

Carrot Medical Places Product with Major Academic Medical Center

Carrot Medical announces a project that will consist of a total of (8) rooms - (3) EP Labs and (5) Cath Labs in the Interventional Cardiology Department at Duke University Hospital.  “Our industry-leading C-Suite solution for Recording, Streaming and Archiving will be in all eight rooms,” said Jeremy Wiggins, Carrot Medical CEO.  The three EP Labs will also have the C-View Pro Large Displays as well as C-Com Wireless Communication Systems. It goes without saying that we are extremely proud of this order. We are looking forward to working with the Interventional Cardiology Team at Duke.”...

Carrot Medical announces a pro...

Read More

Carrot Medical with a Solid 1st Half of 2015

Carrot Medical reports strong Q2, 2015 numbers. Key financial metrics (Revenue, OPEX, and EBITDA) were all favorable. Comparing Q2, 2015 to Q2, 2014 - Revenue increased by 70%, OPEX decreased by 10% and EBITDA improved by 175%. Year to Date Revenue in 2015 increased by 62% over the same period in 2014. “Carrot continues to build on the momentum from Q1,” said Jeremy Wiggins, Carrot Medical CEO. “The market clearly sees a distinction in terms of what Carrot has to offer interventional labs. Our focus and commitment to this space have never wavered and the market is rewarding us for this perseverance.”...

Carrot Medical reports strong ...

Read More